Highly ActiVe Ruthenium(II) NNN Complex Catalysts
Organometallics, Vol. 28, No. 6, 2009 1861
rystalline solid (0.93 g, 65%). Red single crystals suitable for X-ray
crystallographic study were grown by diffusion of diethyl ether
vapor into a saturated solution of the complex in CH2Cl2/MeOH
g, 20.00 mmol), pyrazole (1.77 g, 26.00 mmol), 1,10-phenanthroline
monohydrate (0.79 g, 4.00 mmol), CuI (0.38 g, 2.00 mmol, 10 mol
%), and K2CO3 (3.04 g, 20.00 mmol) in toluene (80 mL) was stirred
at 120 °C for 24 h. After cooling to ambient temperature, the
mixture was filtered through celite, and all the volatiles were
removed under reduced pressure. Isolation by silica gel column
chromatography (petroleum ether (60-90 °C)/ethyl acetate, v/v )
1
(v/v ) 4:1) at ambient temperature. mp: dec > 240 °C. H NMR
(CD2Cl2, 23 °C): δ 8.29 and 7.39 (d each, J ) 7.1 and 7.1 Hz, 1:1
H, 3-H and 5-H), 8.08 (s, 1 H, 4-H), 7.11 and 6.88 (m each, 33 H,
Ph in PPh3, 6′′-H, 7′′-H, and 8′′-H), 6.48 (d, J ) 8.3 Hz, 1 H,
5′′-H), 5.90 (s, 1 H, 4′-H), 2.36 (s, 3 H, C3′-CH3), 2.30 (s, 3 H,
C5′-CH3). 13C{1H} NMR (CD2Cl2, 23 °C): δ 157.2 and 151.2 (s
and Cq each, C2 and C6), 151.9 and 143.4 (s and Cq each, C3′
and C5′), 143.1, 131.8 and 131.5 (s and Cq each, C2′′, C4′′, and
C9′′), 132.8, 132.8, 128.7 and 127.2 (s each, Phenyl CH in PPh3),
131.7 (s, C4), 122.9, 121.6, 114.4 and 112.4 (s each, Phenyl CH),
120.4 and 118.7 (s each, 1:1 CH, C3 and C5), 107.6 (s, C4′), 14.6
(s, C3′-CH3), 14.4 (s, C5′-CH3).31P{1H} NMR (CD2Cl2, 23 °C): δ
21.4. 31P{1H} NMR (CDCl3, 23 °C): δ 22.0. Anal. calcd for
C53H44ClN5P2Ru: C, 67.05; H, 4.67; N, 7.38. Found: C, 66.73; H,
4.71; N, 7.42.
1
40:1) afforded 7 as white solid (2.50 g, 72%). H NMR (CDCl3,
23 °C) δ 10.05 (s, 1 H, CHO), 8.68 (d, J ) 2.4 Hz, 1 H, 3′-H),
8.23 and 7.84 (d each, J ) 8.0 and 7.6 Hz, 2 H, 3-H and 5-H),
7.99 (t, J ) 15.6 Hz, 1 H, 4-H), 7.78 (s, 1 H, 5′-H), 6.52 (s, 1 H,
4′-H). 13C{1H} NMR (CDCl3, 23 °C) δ 192.7 (s, CHO), 151.9 and
151.2 (s and Cq each, C2 and C6), 142.8, 139.9 and 108.5 (s each,
3 × CH, C3′, C4′, and C5′), 127.4 (s, C4), 119.2 and 117.0 (s
each, 2 × CH, C3 and C5).
Synthesis of 2-(Benzoimidazol-2-yl)-6-(pyrazol-1-yl)pyridine
(8). A mixture of aldehyde 7 (0.50 g, 2.89 mmol) and 1,2-
phenylenediamine (0.31 g, 2.89 mmol) in nitrobenzene (50 mL)
was stirred at 150 °C for 12 h. All the volatiles were removed under
reduced pressure and the resultant residue was subject to purification
by flash silica gel column chromatography (CH2Cl2/ethyl acetate,
v/v ) 3:1), affording compound 8 as a pale yellow solid (0.40 g,
Synthesis of Complex 6. A mixture of complex 29 (0.35 g, 0.47
mmol) and DMF/DMSO (20 mL, v/v ) 5:1) was stirred at 100 °C
for 15 min. After cooling to ambient temperature, the resultant
solution was layered with diethyl ether and recrystallized at -20
°C to afford complex 6 as red crystals (0.30 g, 77%). mp: dec >
210 °C.1H NMR (DMSO-d6, 23 °C) δ 15.49 (s, 1 H, NH), 8.40
and 8.23 (d each, J ) 8.0 and 8.0 Hz, 1:1 H, 3-H and 5-H), 7.93
(t, J ) 16.4 Hz, 1 H, 4-H), 7.64 (m, 2 H, 5′′-H and 8′′-H), 7.48 (m,
2 H, 6′′-H and 7′′-H), 7.25 and 7.11 (m each, 9:6 H, Ph in PPh3),
6.45 (s, 1 H, 4′-H), 2.72 (s, 3 H, C3′-CH3), 2.58 (s, 3 H, C5′-CH3),
2.54 (s, 6 H, DMSO). 13C{1H} NMR (DMSO-d6, 23 °C) δ 158.0
and 151.9 (s and Cq each, C2 and C6), 151.8 and 142.1 (s and Cq
each, C3′ and C5′), 149.5, 146.0 and 134.1 (s and Cq each, C2′′,
C4′′, and C9′′), 137.0 (s, C4), 132.7 (d, o-C of PPh3), 130.8 (d, i-C
of PPh3), 129.8 (s, p-C of PPh3), 128.1 (d, m-C of PPh3), 125.5,
124.3, 113.5 and 113.2 (s each, C5”, C6′′, C7′′, and C8′′), 119.3
and 119.1 (s each, C3 and C5), 111.2 (s, C4′), 40.4 (s, CH3 of
DMSO), 14.4 (s, C3′-CH3), 14.2 (s, C5′-CH3). 31P{1H} NMR
(DMSO-d6, 23 °C) δ 31.9. Anal. calcd for C37H36Cl2N5OPRuS: C,
55.43; H, 4.53; N, 8.74. Found: C, 55.40; H, 4.50; N, 8.77.
1
53%). mp: 208-209 °C. H NMR (DMSO-d6, 23 °C) δ 13.10 (s,
1 H, NH), 9.26 (s, 1 H, 3′-H), 8.22 (d, J ) 7.6 Hz, 1 H, 3-H), 8.15
(t, J ) 16.0 Hz, 1 H, 4-H), 7.99 (d, J ) 8.4 Hz, 1 H, 5-H), 7.88 (s,
1 H, 5′-H), 7.75 and 7.64 (d each, J ) 8.0 and 9.2 Hz, 1:1 H, 5′′-H
and 8′′-H), 7.31 and 7.25 (m each, 2 H, 6′′-H and 7′′-H), 6.70 (d,
J ) 1.2 Hz, 1 H, 4′-H). 13C{1H} NMR (DMSO-d6, 23 °C) δ 150.5
and 149.9 (s and Cq each, C2 and C6), 147.0, 144.0 and 134.7 (s
and Cq each, C2′′, C4′′, and C9′′), 142.6 and 140.9 (s each, C3′
and C5′), 128.2 (s, C4), 123.6, 122.1, 112.2 and 111.9 (s each,
phenyl CH), 119.6 and 118.7 (s each, C3 and C5), 108.2 (s, C4′).
HRMS calcd for C15H11N5: 261.1014. Found: 261.1019.
Synthesis of 2-(N-Methyl-benzoimidazol-2-yl)-6-(pyrazol-1-
yl)pyridine (9). A mixture of benzoimidazole 8 (0.68 g, 2.60 mmol)
and Cs2CO3 (1.69 g, 5.20 mmol) in 50 mL DMSO was stirred at
80 °C for 30 min and cooled to ambient temperature. Iodomethane
(0.55 g, 3.90 mmol) was then added, and the reaction was continued
at ambient temperature for 3 h. Dichloromethane (100 mL) was
added, and the resultant mixture was washed with water (3 × 100
mL). The organic phase was separated, dried over anhydrous
MgSO4, and filtered. All the volatiles were evaporated from the
filtrate under reduced pressure, and the resultant residue was subject
to purification by flash silica gel column chromatography (CH2Cl2/
ethyl acetate, v/v ) 3:1), affording 9 as a white solid (0.70 g, 98%).
Synthesis of 6-(Pyrazol-1-yl)pyridine-2-carbaldehyde (7). Com-
pound 7 was prepared using a procedure different from the reported
method.14 A mixture of 6-bromopyridine-2-carbaldedyhyde (3.72
(11) Li, T.; Churlaud, R.; Lough, A. J.; Abdur-Rashid, K.; Morris, R. H.
Organometallics 2004, 23, 6239.
1
(12) (a) Casey, C. P.; Clark, T. B.; Guzei, I. A. J. Am. Chem. Soc. 2007,
129, 11821. (b) Guan, H.; Iimura, M.; Magee, M. P.; Norton, J. R.; Zhu,
G. J. Am. Chem. Soc. 2005, 127, 7805. (c) Chowdhury, R. L.; Bajckvall,
J.-E. J. Chem. Soc., Chem. Commun. 1991, 1063. (d) Aranyos, A.; Csjernyik,
G.; Szabo´, K. J.; Bajckvall, J.-E. Chem. Commun. 1999, 351.
(13) Enthaler, S.; Hagemann, B.; Bhor, S.; Anilkumar, G.; Tse, M. K.;
Bitterlich, B.; Junge, K.; Erre, G.; Beller, M. AdV. Synth. Catal. 2007, 349,
853.
M.p.: 134-135 °C. H NMR (DMSO-d6, 23 °C) δ 8.73 (d, J )
2.1 Hz, 1 H, 3′-H), 8.25 (d, J ) 7.7 Hz, 1 H, 3-H), 8.16 (t, J )
15.8 Hz, 1 H, 4-H), 8.02 (d, J ) 8.1 Hz, 1 H, 5-H), 7.89 (s, 1 H,
5′-H), 7.75 and 7.69 (d each, J ) 8.0 and 8.0 Hz, 1:1 H, 5′′-H and
8′′-H), 7.35 and 7.29 (m each, 2 H, 6′′-H and 7′′-H), 6.65 (d, J )
1.6 Hz, 1 H, 4′-H), 4.29 (s, 3 H, N-CH3). 13C{1H} NMR (DMSO-
d6, 23 °C) δ 150.0 and 148.5 (s and Cq each, C2 and C6), 148.8,
142.0 and 137.1 (s and Cq each, C2′′, C4′′, and C9′′), 142.6 and
(14) Vacher, B.; Bonnaud, B.; Funes, P.; Jubault, N.; Koek, W.; Assie,
M.-B.; Cosi, C. J. Med. Chem. 1998, 41, 5070.